Bladder Cancer Trial, Recruiting NCT07514143 Sponsor: Nucleix Ltd. Condition: Bladder Cancer
Back to Bladder Cancer

Bladder Cancer Trial, Recruiting

NCT07514143
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 22 years of age or older
  • You are willing and able to sign a consent form to participate in the study
  • You are scheduled to have one of the following procedures within the next 60 days: a surgical procedure to remove or examine a bladder tumor (TURBT), a camera examination of the bladder under general anesthesia due to a suspected bladder tumor, or a routine camera check-up of the bladder to monitor a previously diagnosed early-stage bladder condition

Who may not be able to join:

  • You have been diagnosed with, or have a history of, bladder cancer that has grown into the muscle wall of the bladder
  • You have received treatment for prostate cancer or kidney cancer in the past 2 years
  • You have already taken part in this same study within the last 60 days

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +972-8-9161616

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Nucleix Ltd.
Registry
ClinicalTrials.gov
Start date
15 September 2025
Est. completion
1 November 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

The primary objective of the study is to support the Bladder EpiCheck product development studies. There is no measurable endpoint for this study.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov